beta-lactams has been researched along with Bacteremia in 204 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (2.45) | 18.2507 |
| 2000's | 41 (20.10) | 29.6817 |
| 2010's | 114 (55.88) | 24.3611 |
| 2020's | 44 (21.57) | 2.80 |
| Authors | Studies |
|---|---|
| Amoah, J; Chiotos, K; Cosgrove, SE; Klein, EY; Tamma, PD | 1 |
| Hiromatsu, K; Ishikura, H; Kawano, Y; Maruyama, JI; Matsunaga, A; Takamatsu, Y; Takata, T; Togawa, A; Tokushige, C; Yanagihara, I; Yoshimura, M | 1 |
| Andersson, DI; Fatsis-Kavalopoulos, N; Roelofs, L | 1 |
| Chinea, A; Chumbita, M; Cuesta, MA; Español Morales, I; Fernández Abellán, P; Garcia-Vidal, C; González-Sierra, P; Gudiol, C; Guerreiro, M; Lopera, C; Monzó, P; Puerta-Alcalde, P; Rojas, R; Sánchez Pina, JM; Sánchez Vadillo, I; Varela, R; Vázquez, L; Yáñez, L | 1 |
| Almirante, B; Fernández-Hidalgo, N; González-López, JJ; Larrosa, MN; Pigrau, C; Puig-Asensio, M; Rodríguez-Pardo, D; Suanzes, P; Willekens, R | 1 |
| Ahn, JY; Kim, HR; Kim, YC; La, YJ; Oh, DH | 1 |
| Chen, JHK; Davies, J; Gao, P; Halebeedu Prakash, P; Ho, PL; Iu, HTV; Kao, RYT; Li, Y; Tai, SSC; Wan, RE; Wei, Y; Wong, KW; Yam, HCB; Yuen, KY | 1 |
| Hudson, FP; Jaso, TC; McAlister, MJ; Padilla-Tolentino, E; Rose, DT | 1 |
| Lifshitz, Y; Segal, G | 1 |
| Cass, A; Davies, J; Davis, JS; Johnson, SA; Legg, A; Meagher, N; Roberts, JA; Roberts, MA; Scheetz, MH; Tong, SYC | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Huang, SH; Lin, CY; Wang, JT; Yang, JL | 1 |
| Spivak, ES; Sutton, JD | 1 |
| Cai, Y; Wang, J; Wang, Y; Xiao, Q; Xu, J; Zhang, H; Zhu, M | 1 |
| Bonten, MJM; Buis, DTP; Herpers, BL; Jansen, RR; Prins, JM; Rozemeijer, W; Sieswerda, E; Sigaloff, KCE; Soetekouw, R; van der Meer, JTM; van der Vaart, TW; van Twillert, G; van Werkhoven, CH; Veenstra, J | 1 |
| Bjork, L; Cadena, J; Frei, CR; Hopkins, T; Jones, X; Teng, C; Walter, E; Yang, L | 1 |
| Daneman, N; Tong, SYC; Yahav, D | 1 |
| Bavaro, DF; Belati, A; Brindicci, G; Dalfino, L; De Gennaro, N; Dell'Aera, M; Denicolò, S; Di Gennaro, F; Diella, L; Frallonardo, L; Grasso, S; Guido, G; Mosca, A; Papagni, R; Pellegrino, C; Pomarico, F; Ronga, L; Saracino, A; Stufano, M | 1 |
| Hackemann, VCJ; Hagel, S; Jandt, KD; Löffler, B; Rödel, J; Tuchscherr, L | 1 |
| Abdul-Mutakabbir, JC; Alosaimy, S; Bhatia, S; Davis, SL; Jorgensen, SCJ; Lagnf, AM; Mynatt, RP; Rybak, MJ; Sabagha, N; Trinh, TD; Zasowski, EJ | 1 |
| Davis, JS; Holland, TL | 1 |
| Ishida, T; Ito, A; Tachibana, H; Tokumasu, H; Washio, Y; Yamazaki, A | 1 |
| Al-Hasan, MN; Bookstaver, PB; Drennan, C; Gould, AP; Hill, O; Justo, JA; Kohn, J | 1 |
| Blackmore, T; Bloomfield, M; Bupha-Intr, O | 1 |
| Bayer, AS; Chambers, HF; Chen, L; Ersoy, SC; Fowler, VG; Kreiswirth, B; Li, L; Mediavilla, J; Milan, VT; Otmishi, M; Pak, Y; Proctor, RA; Xiong, YQ | 1 |
| Gandhi, TN; Malani, PN | 1 |
| Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
| Gröndahl-Yli-Hannuksela, K; Oksi, J; Rantakokko-Jalava, K; Vahlberg, T; Vilhonen, J; Vuopio, J | 1 |
| Bai, Y; Li, R; Shen, C; Wang, C; Zhang, J | 1 |
| Burgess, DR; Burgess, DS; Wilsey, HA | 1 |
| Holland, TL | 1 |
| Atalla, E; Mylonakis, E | 1 |
| Cheong, E; Darling, AE; Djordjevic, SP; Fourment, M; Gottlieb, T; Hastak, P; Merlino, J; Myers, GSA; Roy Chowdhury, P | 1 |
| Fredlund, H; Källman, J; Liljedahl Prytz, K; Magnuson, A; Prag, M; Sundqvist, M | 1 |
| Blyth, CC; Bowen, AC; Campbell, AJ; McMullan, BJ; McNeil, JC; Montgomery, CP; Tong, SYC | 1 |
| Deng, C; Hu, Y; Liao, L; Liu, L; Wang, C; Wang, Z; Ye, C | 1 |
| Anderson, M; Arensman, K; Beganovic, M; Dela-Pena, J; LaChance, E; Miller, JL; Shields, M | 1 |
| Antsupova, V; Arpi, M; Boel, JB; Holzknecht, BJ; Jarløv, JO; Knudsen, JD | 1 |
| Deng, C; Hu, Y; Liao, L; Sun, L; Wang, C; Wang, Z; Ye, C | 1 |
| Ahmed, N; Decano, A; Dubrovskaya, Y; Jen, SP; Marsh, K; Merchan, C; Papadopoulos, J; Siegfried, J | 1 |
| Afra, K; Lee, C; Mina, N; Saad, S | 1 |
| Blanch Sancho, JJ; García Aragonés, L; Martínez Alfaro, E; Mateos Rodriguez, F; Segura Luque, JC; Solís García Del Pozo, J | 1 |
| Wang, JL; Xu, WH; Yi, YH; Yin, WJ | 1 |
| Chen, IL; Lee, CH; Tsai, CY | 1 |
| Agnello, S; Coe, K; Day, SR; Reed, E; Smith, JM; Wardlow, LC | 1 |
| Crawford, S; Cuenca, J; Ghosh, N; Newton, P; Reynolds, G | 1 |
| Economou, CJP; Lipman, J; McWhinney, B; Roberts, JA; Ungerer, JPJ; Wong, G | 1 |
| McCarthy, KL; Paterson, DL | 1 |
| Albertson, JP; Goto, M; Jones, M; Livorsi, DJ; McDanel, JS; Nair, R; O'Shea, AMJ; Ohl, ME; Perencevich, EN; Roghmann, MC; Schweizer, ML | 1 |
| Baroco, AL; Verma, R | 1 |
| Abdala, E; Akova, M; Álvarez, R; Cano, A; Carratalà, J; Cervera, C; Clemente, WT; Freifeld, A; Gómez, L; Gottlieb, T; Gudiol, C; Gurguí, M; Herrera, F; Maestro-de la Calle, G; Manzur, A; Martín-Dávila, P; Maschmeyer, G; Meije, Y; Montejo, M; Peghin, M; Rodríguez-Baño, J; Royo-Cebrecos, C; Ruiz-Camps, I; Sukiennik, TC; Tebe, C | 2 |
| Tamma, PD; Villegas, MV | 1 |
| Barriga, Á; Bravo-Ferrer, J; Delgado, M; Lavín-Alconero, L; López-Cortés, LE; Lupión, C; Núñez-Núñez, M; Retamar, P; Rodríguez-Baño, J; Rosso-Fernández, C | 1 |
| Al-Hasan, MN; Albrecht, HA; Bookstaver, PB; Hammer, KL; Justo, JA; Kohn, J; Nimmich, EB; Smith, TJ; Troficanto, C | 1 |
| Klevišar, MN; Lusa, L; Pirš, M; Premru, MM; Strle, F; Stupica, D; Terzić, S | 1 |
| Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Ohmagari, N; Takeshita, N; Yamamoto, K | 1 |
| Bartash, R; Nori, P | 1 |
| Beyda, ND; Bowers, DR; Casapao, AM; Dilworth, TJ; Jacobs, DM | 1 |
| Kollef, MH; Micek, ST; Vazquez, R; Vazquez-Guillamet, MC | 1 |
| Mercuro, NJ; Stogsdill, P; Wungwattana, M | 1 |
| Anderson, DJ; Fletcher, JM; Kram, BL; Kram, SJ; Sarubbi, CB | 1 |
| Chang, SC; Chen, PY; Chen, YC; Chuang, YC; Lin, CY; Wang, JT | 1 |
| Bernhard, M; Brenner, T; Briegel, J; Brinkmann, A; Dubler, S; Grabein, B; Hecker, A; Heininger, A; Hochreiter, M; Hoppe-Tichy, T; Kruger, WA; Lichtenstern, C; Mayer, K; Pinder, N; Pletz, MW; Richter, DC; Storzinger, D; Weigand, MA; Weiterer, S; Zimmermann, S | 1 |
| Fung, CP; Lin, YT; Wang, FD; Wu, PF; Yang, TC | 1 |
| Li, Y; Liu, J; Liu, Y; Shen, L; Yu, J; Zhu, W | 1 |
| Davis, SL; Herc, ES; Mercuro, NJ; Zervos, MJ | 1 |
| Månsson, V; Resman, F; Riesbeck, K; Thegerström, J | 1 |
| Geriak, M; Nizet, V; Sakoulas, G | 1 |
| Askin, G; Christos, P; Sfeir, MM | 1 |
| Guo, Q; Hu, F; Li, Y; Su, J; Wang, M; Wu, S; Xu, S | 1 |
| Bartoletti, M; Giannella, M; Lewis, RE; Tedeschi, S; Viale, P | 1 |
| Fosse, N; Frei, R; Tschudin-Sutter, S; Widmer, AF | 1 |
| Al-Hasan, MN; Bookstaver, PB; Dash, S; Haggard, E; Justo, JA; Kohn, J; Mediwala, KN; Rac, H; Seddon, MM | 1 |
| Drouin, H; Javaugue, FC; Lefebvre, M; Lefèvre, B; Piau, C; Poinsignon, Y; Talarmin, JP; Tattevin, P; Varache, N | 1 |
| Ardanuy, C; Carratalà, J; Cuervo, G; Domínguez, MA; Grau, I; Grillo, S; Gudiol, C; Guillem Tió, L; Murillo, O; Pallarès, N; Pujol, M; Shaw, E; Tebé, C | 1 |
| Beyda, ND; Bowers, DR; Casapao, AM; Dilworth, TJ; Ibrahim, OM; Jacobs, DM; Mercier, RC | 1 |
| Ambretti, S; Bartoletti, M; Ferraro, G; Furii, F; Giannella, M; Lewis, RE; Pancaldi, L; Pascale, R; Tedeschi, S; Toschi, A; Viale, P | 1 |
| Baldassarre, M; Barsic, B; Bartoletti, M; Bernardi, M; Bruns, T; Burra, P; Calbo, E; Caraceni, P; Cobos-Trigueros, N; D'Offizi, G; Domenicali, M; Galan-Ladero, MA; Giannella, M; Lewis, RE; Maraolo, AE; Merli, M; Muñoz, P; Paul, M; Petrosillo, N; Retamar, P; Rodriguez-Baño, J; Schramm, C; Seminari, E; Tedeschi, S; Torrani Cerenzia, M; Tumbarello, M; Verucchi, G; Viale, P; Zak-Doron, Y | 1 |
| Achermann, Y; Benussi, S; Boumasmoud, M; Dengler Haunreiter, V; Häffner, N; Kühnert, D; Leimer, N; Rachmühl, C; Vulin, C; Wipfli, D; Zbinden, R; Zinkernagel, AS | 1 |
| Barceló, IM; Jordana-Lluch, E; Juan, C; Oliver, A; Sánchez-Diener, I; Torrens, G; Zamorano, L | 1 |
| Bliziotis, IA; Falagas, ME; Tansarli, GS; Vardakas, KZ | 1 |
| Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I | 1 |
| Bertrand, S; Glupczynski, Y; Jacobs, J; Lejon, V; Lunguya, O; Muyembe-Tamfum, JJ; Phoba, MF; Vanhoof, R; Verhaegen, J | 1 |
| Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M | 1 |
| Castanheira, M; Deshpande, LM; Farrell, SE; Jones, RN; Mendes, RE | 1 |
| Bonten, MJ; Cohen Stuart, JW; Dorigo-Zetsma, JW; Frakking, FN; Kluytmans, JA; Leverstein-van Hall, MA; Lutgens, SP; Prins, JM; Rottier, WC; Thijsen, SF; van Hattem, JM; van Hees, BC; Verbon, A; Vlaminckx, BJ | 1 |
| Cosgrove, SE; Harris, AD; Hsu, AJ; Milstone, AM; Tamma, PD; Turnbull, AE | 1 |
| Bleasdale, SC; McConeghy, KW; Rodvold, KA | 1 |
| Beardsley, JR; Johnson, JW; Koliscak, LP; Luther, VP; Miller, DP; Ohl, CA; Williamson, JC | 1 |
| Dilworth, TJ; Hall, P; Ibrahim, O; Mercier, RC; Sliwinski, J; Walraven, C | 1 |
| Bodro, M; Boix, L; Calvo, M; Carratalà, J; Contra, A; Domingo-Domenech, E; Garcia-Vidal, C; Gudiol, C; Tubau, F | 1 |
| Jung, JS; Kostrzewa, M; Lange, C; Popp, C; Schubert, S; Sparbier, K | 1 |
| Cleveland, KO; Gelfand, MS; Mazumder, SA | 1 |
| Sick, AC; Tamma, PD; Tschudin-Sutter, S; Turnbull, AE; Weissman, SJ | 1 |
| Boyer, MW; Goulston, C; Hanson, KE; Kim, JH; Tricot, G; Zangari, M | 1 |
| Alshabani, K; Bathina, P; Dalle, D; Gudur, UM; Hayakawa, K; Jaydev, F; Kaye, KS; Khatri, J; Lephart, PR; Marchaim, D; Martin, ET; Muppavarapu, KS; Pogue, JM; Rajuri, SD; Rybak, MJ; Sundaragiri, PR | 1 |
| Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC | 1 |
| Chambers, HF | 1 |
| Dilworth, TJ; Ibrahim, OM; Mercier, RC | 1 |
| Dhand, A; Sakoulas, G | 1 |
| Chaubey, VP; Dalton, B; Gregson, DB; Laupland, KB; Pitout, JD; Ross, T | 1 |
| Bruno, JJ; Dee, BM; Qiao, W; Smith, ZR; Tajchman, SK; Tverdek, FP | 1 |
| Artacho-Reinoso, MJ; Aznar-Martín, J; Lepe-Jiménez, JA; Ruiz-Castillo, A; Torres-Sánchez, MJ | 1 |
| Avdic, E; Carroll, KC; Cosgrove, SE; Smith, JM; Tamma, PD; Zhang, L | 1 |
| D'Agostino, C; Rhodes, NJ; Roberts, JA; Scheetz, MH; Skoglund, E | 1 |
| Gentry, CA; Williams, RJ | 1 |
| Berkowitz, NM; Campos, J; DeBiasi, RL; Singh, N; Spaeder, MC | 1 |
| Abbo, LM; Rosa, R; Sfeir, M; Smith, L; Wawrzyniak, A | 1 |
| Carraro, F; Caselli, D; Castagnola, E; Cesaro, S; Colombini, A; Fagioli, F; Meazza, C; Zanazzo, G; Ziino, O | 1 |
| Cprek, JB; Gallagher, JC | 1 |
| Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V | 1 |
| Leung, V; Romney, M; Wong, D; Wong, T | 2 |
| Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; de Cueto, M; Gasch, O; Giamarellou, H; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hernández, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Molina, J; Mora-Rillo, M; Natera, C; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pérez-Galera, S; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Salamanca, E; Schwaber, MJ; Souli, M; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P | 1 |
| Blumenthal, KG; Huang, M; Kuhlen, JL; Parker, RA; Shenoy, ES; Walensky, RP; Ware, WA | 1 |
| Charles, PG; Cherkaoui, A; Emonet, S; Harbarth, S; Renzi, G; Rougemont, M; Schrenzel, J; Stewardson, AJ; Uckay, I | 1 |
| Kumaraswamy, M; Nizet, V; Olson, J; Pogliano, J; Quach, DT; Rybak, MJ; Sakoulas, G; Singh, NB; Yim, J | 1 |
| Álvarez, C; Ardila, N; Ariza, B; Caro, MA; Gil, F; González, PF; Valderrama, SL | 1 |
| Chelaghma, W; Kassah-Laouar, A; Loucif, L; Messala, A; Rolain, JM; Saidi, M | 1 |
| Bitterman, R; Geffen, Y; Paul, M; Polak, D | 1 |
| Al-Hasan, MN; Albrecht, H; Bookstaver, PB; Hammer, KL; Justo, JA; Kohn, J | 1 |
| Falagas, ME; Trigkidis, KK; Vardakas, KZ | 1 |
| Al-Hasan, MN; Albrecht, H; Augustine, MR; Bookstaver, PB; Justo, JA; Kohn, J; Testerman, TL | 1 |
| Echevarria, KL; Li, J; Traugott, KA | 1 |
| Cho, SY; Chung, DR; Ha, YE; Kang, CI; Ko, JH; Lee, NY; Park, GE; Peck, KR; Song, JH | 1 |
| Basso, M; Costa, SF; Gobara, S; Gomez, LB; Levin, AS; Oshiro, I; Paez, JG; Spadão, F | 1 |
| Pascual, A; Rodríguez-Baño, J | 1 |
| Dunne, WM; Fraser, VJ; Frye, JG; Marschall, J; Tibbetts, RJ; Warren, DK | 1 |
| Chan, J; Leo, YS; Lye, DC; Teng, CP; Wijaya, L | 1 |
| Almela, M; Marco, F; Martínez, JA; Mensa, J; Muñoz, A; Ortega, M; Soriano, A | 1 |
| Al-Hasan, MN; Baddour, LM; Eckel-Passow, JE; Lahr, BD; Thomsen, KM; Tleyjeh, IM; Vetter, EA; Wilson, JW | 1 |
| Abeysinghe, N; Batuwanthudawe, R; Dassanayake, M; de Silva, S; Karunarathne, K; Lalitha, MK; Steinhoff, M; Thomas, K | 1 |
| Cuadrado Pastor, JM; Jover Díaz, F; Martín González, C; Mayol Belda, MJ | 1 |
| Matull, WR; Morgan, MY; O'Beirne, J; O'Neill, S; Smith, R; Wright, G; Zambreanu, L | 1 |
| Bejon, P; Bowler, IC; Walker, TM | 1 |
| Almela, M; López, J; López-Dupla, M; Marco, F; Martínez, JA; Mensa, J; Olona, M; Soriano, A; Vidal, F | 1 |
| Blot, S; Memon, JI | 1 |
| Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H | 1 |
| Ishibashi, Y; Kitamura, J; Sakane, T; Sato, H; Sato, M; Shimada, T; Takahashi, N; Tanabe, K; Yoshitomi, H | 1 |
| Aarestrup, FM; Bangtrakulnonth, A; Hasman, H; Hendriksen, RS; Pornruangmong, S; Pulsrikarn, C; Samulioniené, J; Schønheyder, HC; Sirichote, P | 1 |
| Hwang, KP; Shen, YH; Tang, YF | 1 |
| Ferreira, S; Mendo, S; Paradela, A; Ramalheira, E; Velez, J; Walsh, TR | 1 |
| Muir, A; Weinbren, MJ | 1 |
| Almela, M; Cobos-Trigueros, N; Lopez, J; Marco, F; Martínez, JA; Mensa, J; Ortega, M; Pitart, C; Soriano, A; Sterzik, H | 1 |
| Hasegawa, Y; Hatakeyama, K; Kawamura, I; Kojima, S; Ohkura, T; Ohkusu, K; Takahashi, Y; Yagi, T | 1 |
| Bishara, J; Leibovici, L; Lev, B; Lishtzinsky, Y; Paul, M; Samra, Z; Talker, O; Zemer-Wassercug, N | 1 |
| Andresen, D; Burbury, K; Dawson, L; Kelly, A; Lingaratnam, S; O'Reilly, M; Slavin, MA; Tam, CS; Thursky, KA; Turnidge, J; Worth, LJ | 1 |
| Chung, KP; Hsueh, PR; Huang, YT; Teng, LJ; Tsai, TH; Tseng, SP | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC | 1 |
| Bencardino, A; Carattoli, A; Falcone, M; García-Fernández, A; Gianfreda, R; Giordano, A; Orsi, GB; Venditti, C; Venditti, M | 1 |
| Balada-Llasat, JM; Buckosh, M; Hemminger, J; Pancholi, P; Raczkowski, M | 1 |
| Fujita, N; Satake, S; Shime, N | 1 |
| Chen, CP; Chen, TL; Fung, CP; Huang, LJ; Kuo, SC; Lee, YT; Liang-Yu, C; Liu, CY; Luo, BS | 1 |
| Al Naiemi, N; Arents, N; Diederen, B; Fluit, A; Leverstein-van Hall, M; Mouton, JW; Stuart, JC; Thijsen, S; Vlaminckx, B | 1 |
| Bayer, AS; Bolaris, M; Dhand, A; Nizet, V; Pogliano, J; Sakoulas, G; Wang, G; Yang, SJ | 1 |
| Aguado, JM; Chaves, F; Gómez-Gonzalez, C; Lalueza, A; Rodríguez-Otero, J; San-Juan, R; Sanz, F | 1 |
| Al Akhrass, F; Chaftari, AM; Chandra, J; Ghannoum, M; Hachem, R; Haydoura, S; Kontoyiannis, DP; Mohamed, JA; Raad, I; Tarrand, J | 1 |
| Ashley, ED; Brown, J; Brown, K; Butterfield, JM; Forrest, A; Hardy, D; Lodise, TP; Tsuji, BT | 1 |
| Bliziotis, IA; Falagas, ME; Michalopoulos, A; Petrosillo, N; Samonis, G | 1 |
| Chang, SC; Chen, WC; Chen, YC; Hu, FC; Wang, JL; Wu, UI; Yang, CS | 1 |
| Boo, TW; Boyle, F; Cotter, M; Khan, A; O'Connell, B | 1 |
| Bayer, AS; Mishra, NN; Moise, PA; Nizet, V; Pogliano, J; Sakoulas, G; Tsuji, BT; Yang, SJ; Yeaman, MR | 1 |
| Chang, HJ; Chia, JH; Kuo, AJ; Lee, MH; Liu, SW; Wu, TL | 1 |
| Chang, CM; Chen, PL; Chiu, YC; Ko, WC; Lee, CC; Lee, HC; Lee, NY; Lin, YT; Wu, CJ; Wu, JJ; Yan, JJ | 1 |
| Bathina, P; Bheemreddy, S; Chalana, IK; Hasan, A; Hayakawa, K; Kamatam, S; Kaye, KS; Kotra, H; Ku, K; Kumar, S; Lee, DW; Lephart, PR; Marchaim, D; Martin, ET; Nanjireddy, P; Patel, S; Pogue, JM; Pulluru, H; Rybak, MJ; Sheth, P; Sunkara, B; Swan, J; Tiwari, N; Vahia, A; Yee, V; Yousuf, A | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
| Chan, JF; Cheng, VC; Curreem, SO; Lau, SK; Leung, SS; To, KK; Woo, PC; Yuen, KY | 1 |
| Beekmann, SE; Diekema, DJ; Ernst, EJ; Herwaldt, L; Johannsson, B; Johnson, SJ; Polgreen, PM | 1 |
| Amyes, SG; Dimude, JU | 1 |
| Futo, M; Hara, S; Ishikawa, T; Ishikura, H; Kamimura, H; Matsunaga, A; Miyazaki, M; Nishida, T; Shiotsuka, S; Takata, T; Tamura, K; Tsuji, BT; Yoshimura, H | 1 |
| Carmeli, Y; Chmelnitsky, I; Karfunkel, D; Kotlovsky, T; Navon-Venezia, S | 1 |
| Koh, TH; Krishnan, PU; Lim, TP; Lye, D; Marimuthu, K; Ng, TM; Tan, TY; Teng, C | 1 |
| Amodio-Groton, M; Hoffman-Roberts, HL; Lamp, KC; Moise, PA; Rashid, M; Rastogi, A; Sakoulas, G; Schweitzer, S; Yoon, MJ | 1 |
| Goldstein, EJ | 1 |
| Almela, M; García, E; Horcajada, JP; Marco, F; Marco, MA; Martínez, JA; Mensa, J; Soriano, A; Torres, A | 1 |
| Peetermans, WE; Van Kerkhoven, D; Verbist, L; Verhaegen, J | 1 |
| Cuenca, M; de Górgolas, M; Fernández Guerrero, ML; Fernández Roblas, R; Marrero, J; Ramos, JM | 1 |
| Agarwal, SK; Gupta, MK; Jain, A; Kumar, M; Roy, I | 1 |
| Allouch, PY; Decousser, JW; Picot, F; Pina, P | 1 |
| Huang, ST; Ko, WC; Lee, HC; Lee, NY; Liu, KH; Yan, JJ | 1 |
| Allouch, P; Decousser, JW; Methlouthi, I; Pina, P | 1 |
| Chryssouli, Z; Galani, I; Giamarellou, H; Orlandou, K; Souli, M | 1 |
| Dolna, I; Franiczek, R; Krzyzanowska, B; Mokracka, G; Szufnarowski, K | 1 |
| Cirioni, O; D'Amato, G; Giacometti, A; Kamysz, W; Licci, A; Lukasiak, J; Nadolski, P; Riva, A; Scalise, G; Silvestri, C | 1 |
| Fakih, MG; Johnson, LB; Khatib, R; Riederer, K; Saeed, S; Sharma, M | 1 |
| Cai, P; Chang, D; Mi, Z; Wang, C | 1 |
| Harbarth, S; Nobre, V; Pittet, D | 1 |
| Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK | 1 |
| Bonnaure-Mallet, M; Jolivet-Gougeon, A; Sixou, JL; Tamanai-Shacoori, Z | 1 |
| Dimopoulos, G | 1 |
| Chan, J; Chen, HH; Lye, DC; Teng, CP | 1 |
| Fung, CP; Huang, SS; Lee, CW; Lee, N; Lee, SC; Shieh, WB; Siu, LK | 1 |
| Bajolet, O; Berthelot, P; Bingen, E; Couetdic, G; Favre, R; Grattard, F; Hocquet, D; Husson, MO; Jeannot, K; Mariani-Kurkdjian, P; Marty, N; Plésiat, P; Roussel-Delvallez, M | 1 |
| Choe, KW; Kim, EC; Kim, HB; Kim, KH; Kim, NJ; Kim, SH; Oh, MD | 1 |
| Cueto, Md; Gálvez, J; Muniain, MA; Navarro, MD; Pascual, A; Perea, EJ; Rodríguez-Baño, J; Romero, L | 1 |
| Apisarnthanarak, A; Dejsirilert, S; Kiratisin, P; Kitphati, R; Mundy, LM; Saifon, P | 1 |
| Chen, HE; Cheng, KC; Chuang, YC; Ko, WC; Lee, CC; Yu, WL | 1 |
| Alcaide, F; Benitez, MA; Carratala, J; Gudiol, F; Liñares, J; Martin, R; Pallares, R | 1 |
| Aucouturier, C; Caron, F; Lemeland, JF; Martin, E; Pestel, M | 1 |
| Berkowitz, F; Crellin, J; Hill, B; Jay, C; Medeiros, AA; Metchock, B; Rasheed, JK; Steward, C; Tenover, FC; Weigel, L | 1 |
| Seifert, H | 1 |
| Chang, SC; Ho, M; Hsueh, PR; Lee, CY; Lin, FM; Lu, PL; Luh, KT; Siu, LK | 1 |
| Aguilar, C; Becerra, Z; Echániz, G; Garza-Ramos, U; Gatica, R; Leaños, B; Miranda, G; Silva, J; Solórzano, F; Velázquez, M | 1 |
| Aguilar, L; Casal, J; Fenoll, A; Giménez, MJ; Jado, I; Yuste, J | 1 |
22 review(s) available for beta-lactams and Bacteremia
| Article | Year |
|---|---|
Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lactams; Randomized Controlled Trials as Topic; Sepsis | 2023 |
Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
Clinical Management of
Topics: Adolescent; Age Factors; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Catheter-Related Infections; Cephalosporins; Child; Child, Preschool; Delphi Technique; Drug Administration Schedule; Echocardiography; Endocarditis, Bacterial; Glycopeptides; Humans; Incidence; Infant; Infant, Newborn; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Penicillins; Randomized Controlled Trials as Topic; Referral and Consultation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2020 |
Systematic review and meta-analysis of the efficacy and safety of vancomycin combined with β-lactam antibiotics in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cloxacillin; Daptomycin; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2022 |
Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Vancomycin | 2021 |
Beta-lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: A summary and appraisal of the evidence.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Staphylococcus aureus; Vancomycin-Resistant Enterococci | 2017 |
Bacterial sepsis : Diagnostics and calculated antibiotic therapy.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactams; Biomarkers; Drug Monitoring; Humans; Intensive Care Units; Shock, Septic | 2019 |
Combatting resistant enterococcal infections: a pharmacotherapy review.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Urinary Tract Infections | 2018 |
Is a Reported Penicillin Allergy Sufficient Grounds to Forgo the Multidimensional Antimicrobial Benefits of β-Lactam Antibiotics?
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Diagnostic Tests, Routine; Drug Hypersensitivity; Humans; Staphylococcal Infections | 2019 |
Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Observational Studies as Topic; Survival Analysis; Treatment Outcome; Young Adult | 2018 |
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Infusions, Intravenous; Liver Cirrhosis; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Time Factors | 2018 |
Chronic meningococcemia: a report of 26 cases and literature review.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Chronic Disease; Female; France; Humans; Incidence; Infusions, Parenteral; Male; Meningococcal Infections; Middle Aged; Prognosis; Young Adult | 2019 |
β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Fluoroquinolones; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2013 |
Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Therapy, Combination; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2014 |
Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
Topics: Adult; Bacteremia; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Hospitalization; Humans; Macrolides; Odds Ratio; Pneumonia, Bacterial; Shock, Septic; Treatment Outcome | 2017 |
β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Humans; Methicillin; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Clinical significance of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors | 2008 |
Does antibiotic selection impact patient outcome?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia, Pneumococcal; Prognosis; Sepsis; Survival Rate | 2007 |
Antimicrobial treatment of Capnocytophaga infections.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Cilastatin; Clindamycin; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests | 2007 |
6 trial(s) available for beta-lactams and Bacteremia
| Article | Year |
|---|---|
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Drug-Related Side Effects and Adverse Reactions; Humans; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Administration Routes; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections; Research Design; Treatment Outcome | 2017 |
Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus β-lactams.
Topics: Administration, Oral; Aged; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
Rapid molecular determination of methicillin resistance in staphylococcal bacteraemia improves early targeted antibiotic prescribing: a randomized clinical trial.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Time-to-Treatment | 2016 |
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Cohort Studies; Female; Hospitals, University; Humans; Korea; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
176 other study(ies) available for beta-lactams and Bacteremia
| Article | Year |
|---|---|
Administration of a β-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans; Lactams; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2022 |
Emerging resistance to beta-lactams in Pantoea ananatis isolated from an immunocompetent patient with bacteremia.
Topics: Bacteremia; beta-Lactams; Humans; Pantoea | 2022 |
Potential risks of treating bacterial infections with a combination of β-lactam and aminoglycoside antibiotics: A systematic quantification of antibiotic interactions in E. coli blood stream infection isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; beta-Lactams; Drug Synergism; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests | 2022 |
Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Febrile Neutropenia; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa; Retrospective Studies; Sepsis; Spain | 2022 |
Empirical use of β-lactam/β-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactams; Cefazolin; Cloxacillin; Cohort Studies; Humans; Lactams; Methicillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Glycopeptides; Humans; Methicillin; Nafcillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2022 |
Subinhibitory Concentrations of Antibiotics Exacerbate Staphylococcal Infection by Inducing Bacterial Virulence.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Peritonitis; Reproducibility of Results; Staphylococcal Infections; Tetracycline; Virulence Factors | 2022 |
Oral β-lactams vs fluoroquinolones and trimethoprim/sulfamethoxazole for step-down therapy for Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Escherichia coli; Fluoroquinolones; Humans; Klebsiella pneumoniae; Proteus mirabilis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
[A RARE COMBINATION OF DELAYED TYPE HYPERSENSITIVITY REACTIONS TO BETA-LACTAMS IN A PATIENT WITH MSSA BACTEREMIA].
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Hypersensitivity; Exanthema; Humans; Hypersensitivity, Immediate; Male; Methicillin; Penicillins; Skin Tests; Staphylococcal Infections | 2022 |
The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Monobactams; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Oral step-down with β-lactams for uncomplicated Enterobacterales bacteraemia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans | 2023 |
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ceftriaxone; Cefuroxime; Floxacillin; Humans; Methicillin; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefpodoxime; Cohort Studies; Fluoroquinolones; Humans; Infant, Newborn; Retrospective Studies | 2023 |
Which trial do we need? Highly bioavailable oral β-lactams versus quinolones or trimethoprim-sulfamethoxazole for gram-negative bacteraemia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Propensity Score; Retrospective Studies; Sepsis | 2023 |
The Controversial Effect of Antibiotics on Methicillin-Sensitive
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Biofilms; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
Combination Therapy for MRSA Bacteremia: To ß or Not to ß?
Topics: Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections | 2020 |
Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Bacteremia; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Survival Analysis | 2019 |
Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Retrospective Studies; Risk Factors; Sepsis | 2020 |
Efficacy of Early Oral Switch with β-Lactams for Low-Risk
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2020 |
Scope and Predictive Genetic/Phenotypic Signatures of Bicarbonate (NaHCO
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Phenotype; Predictive Value of Tests; Prevalence; Sodium Bicarbonate; Staphylococcal Infections | 2020 |
Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time.
Topics: Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Finland; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Referral and Consultation; Retrospective Studies; Streptococcal Infections; Streptococcus; Streptococcus pyogenes | 2020 |
Use of Monte Carlo simulation to optimize antibiotic selection for bloodstream infections caused by Enterobacteriaceae in Shandong Province, China.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; China; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Monte Carlo Method | 2020 |
Early Oral Antibiotic Switch for
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans; Prospective Studies; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2020 |
In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2020 |
Topics: Anti-Bacterial Agents; Australia; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2020 |
Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Gentamicins; Hospitalization; Humans; Male; Organ Dysfunction Scores; Retrospective Studies; Sepsis | 2020 |
Fluoroquinolone versus Beta-Lactam Oral Step-Down Therapy for Uncomplicated Streptococcal Bloodstream Infections.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Fluoroquinolones; Humans; Retrospective Studies; Sepsis; Streptococcus | 2020 |
Intravenous mecillinam compared with other β-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract; Urinary Tract Infections | 2021 |
Intravenous push versus intravenous piggyback beta-lactams for the empiric management of gram-negative bacteremia.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies | 2021 |
Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Blood Culture; Clostridioides difficile; Clostridium Infections; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2020 |
Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Fever; Humans; Logistic Models; Male; Middle Aged; Propensity Score; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Treatment Outcome | 2021 |
Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2021 |
Penicillin versus anti-staphylococcal beta-lactams for penicillin-susceptible Staphylococcus aureus blood stream infections: a retrospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Female; Humans; Male; Penicillins; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Critical Care; Critical Illness; Cross Infection; Drug Monitoring; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Renal Replacement Therapy; Retrospective Studies; Tertiary Care Centers; Young Adult | 2017 |
Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Retrospective Studies; Risk Factors; Tertiary Care Centers; Young Adult | 2017 |
Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Male; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2017 |
Topics: Aged; Ampicillin; Bacteremia; beta-Lactams; Clostridioides difficile; Diagnosis, Differential; Enterococcus faecalis; Gram-Positive Bacterial Infections; Hepatitis A; Humans; Infusions, Intravenous; Male; Vancomycin | 2017 |
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Neutropenia | 2017 |
Use of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population.
Topics: Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Catheter-Related Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Propensity Score; Urinary Tract Infections | 2017 |
Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.
Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactams; Blood Culture; Carbapenems; Gram-Negative Bacteria; Humans; Prospective Studies | 2017 |
Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Male; Retrospective Studies; Urinary Tract Infections | 2017 |
Bacteraemic urinary tract infections in a tertiary hospital in Japan: the epidemiology of community-acquired infections and the role of non-carbapenem therapy.
Topics: Bacteremia; beta-Lactams; Enterobacteriaceae; Humans; Japan; Tertiary Care Centers; Urinary Tract Infections | 2017 |
Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
Predicting Resistance to Piperacillin-Tazobactam, Cefepime and Meropenem in Septic Patients With Bloodstream Infection Due to Gram-Negative Bacteria.
Topics: Adult; Aged; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Decision Trees; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Factors | 2017 |
Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2019 |
A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Drug Therapy, Combination; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vancomycin-Resistant Enterococci | 2018 |
Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ciprofloxacin; Cohort Studies; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome | 2018 |
Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Benzylpenicillin versus wide-spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections in adults; a retrospective propensity score-matched study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Hospitalization; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Pneumonia; Propensity Score; Respiratory Tract Infections; Retrospective Studies; Sweden; Young Adult | 2018 |
Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Case-Control Studies; Cefoperazone; China; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam | 2018 |
Combination therapy for treatment of Pseudomonas aeruginosa bloodstream infections.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Switzerland | 2018 |
Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactams; Clostridioides difficile; Clostridium Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; South Carolina; Time Factors | 2019 |
Impact of β-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score-matched Analysis.
Topics: Aged; Bacteremia; beta-Lactams; Daptomycin; Female; Humans; Male; Methicillin; Middle Aged; Propensity Score; Retrospective Studies; Staphylococcus aureus | 2019 |
Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Observational Studies as Topic; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2019 |
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactams; Enterobacteriaceae Infections; Female; Humans; Incidence; Italy; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Failure; Young Adult | 2019 |
Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Piperacillin; Prospective Studies; Retrospective Studies; Tazobactam; Treatment Outcome | 2019 |
In-host evolution of Staphylococcus epidermidis in a pacemaker-associated endocarditis resulting in increased antibiotic tolerance.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactams; Biofilms; Drug Resistance, Multiple; Drug Tolerance; Endocarditis; Evolution, Molecular; Fluoroquinolones; Glycopeptides; Host-Pathogen Interactions; Humans; INDEL Mutation; Male; Microbial Sensitivity Tests; Pacemaker, Artificial; Peptides, Cyclic; Phylogeny; Polymorphism, Single Nucleotide; Staphylococcal Infections; Staphylococcus epidermidis | 2019 |
In Vivo Validation of Peptidoglycan Recycling as a Target to Disable AmpC-Mediated Resistance and Reduce Virulence Enhancing the Cell-Wall-Targeting Immunity.
Topics: Animals; Bacteremia; Bacterial Load; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ceftazidime; Cell Wall; Disease Models, Animal; Female; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Peptidoglycan; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Survival Analysis; Treatment Outcome; Virulence | 2019 |
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Antimicrobial resistance in invasive non-typhoid Salmonella from the Democratic Republic of the Congo: emergence of decreased fluoroquinolone susceptibility and extended-spectrum beta lactamases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Blood; Child; Child, Preschool; Democratic Republic of the Congo; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Salmonella; Salmonella Infections; Serotyping; Young Adult | 2013 |
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome | 2013 |
Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).
Topics: Bacteremia; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Sequence Analysis, DNA; United States | 2013 |
Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Comorbidity; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2013 |
Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Comparative Effectiveness Research; Creatine; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infant; Kidney Diseases; Logistic Models; Male; Propensity Score; Retrospective Studies; Treatment Outcome | 2013 |
Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Empirical Research; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Risk; Tetracycline; Urinary Tract Infections | 2013 |
β-Lactams enhance vancomycin activity against methicillin-resistant Staphylococcus aureus bacteremia compared to vancomycin alone.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Neoplasms | 2014 |
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of β-lactam resistance in Enterobacteriaceae derived from blood cultures.
Topics: Bacteremia; beta-Lactam Resistance; beta-Lactams; Blood; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Common use of the empirical combination of vancomycin and a β-lactam for staphylococcal bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2014 |
Empiric combination therapy for gram-negative bacteremia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Baltimore; beta-Lactams; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Empiricism; Female; Gram-Negative Bacterial Infections; Humans; Infant; Kaplan-Meier Estimate; Male; Neutropenia; Odds Ratio; Opportunistic Infections; Propensity Score; Retrospective Studies; Survival Analysis | 2014 |
Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Outpatients; Peripheral Blood Stem Cell Transplantation; Retrospective Studies | 2014 |
Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Daptomycin; Female; Gram-Positive Bacterial Infections; Hospital Costs; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Severity of Illness Index; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2014 |
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2014 |
Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2014 |
Reply to "Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia".
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2014 |
Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.
Topics: Adult; Aged; Alberta; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Population Surveillance | 2014 |
Development of a combination antibiogram for Pseudomonas aeruginosa bacteremia in an oncology population.
Topics: Administration, Intravenous; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Medical Oncology; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2016 |
[The relevance of correct identification and interpretation of susceptibility testing of Aeromonas spp. bacteremia isolates].
Topics: Aeromonas; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Humans; Microbial Sensitivity Tests | 2016 |
Risk Factors for Resistance to β-Lactam/β-Lactamase Inhibitors and Ertapenem in Bacteroides Bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacteroides; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2015 |
Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Endocarditis; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2015 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Empiric Monotherapy Versus Combination Therapy for Enterobacteriaceae Bacteremia in Children.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Retrospective Studies | 2015 |
Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cross Infection; Echocardiography; Female; Florida; Hospital Mortality; Hospitals, Teaching; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy.
Topics: Adolescent; Antineoplastic Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Infant; Infant, Newborn; Italy; Male; Neoplasms; Prospective Studies; Retrospective Studies; Survival Analysis | 2016 |
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections | 2016 |
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins | 2016 |
Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2016 |
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies | 2016 |
Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Canada; Cohort Studies; Female; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2016 |
The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Hypersensitivity; Female; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Retrospective Studies; Skin Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Disease Models, Animal; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Ertapenem; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Staphylococcal Infections; Staphylococcal Skin Infections | 2016 |
Risk factors for hospital-acquired bacteremia due to carbapenem-resistant Pseudomonas aeruginosa in a Colombian hospital.
Topics: Bacteremia; beta-Lactams; Carbapenems; Case-Control Studies; Ciprofloxacin; Drug Resistance, Bacterial; Ertapenem; Hospitals; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Thienamycins | 2016 |
Outbreak of OXA-48-Producing Klebsiella pneumoniae Involving a Sequence Type 101 Clone in Batna University Hospital, Algeria.
Topics: Algeria; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clone Cells; Conjugation, Genetic; Disease Outbreaks; Ertapenem; Gene Expression; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nephritis; Phylogeny; Plasmids | 2016 |
Morphological changes induced by β-lactam antibiotics observed on Gram staining.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ertapenem; Gentian Violet; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Osteomyelitis; Phenazines | 2017 |
Differential effect of prior β-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Assessment | 2017 |
Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Assessment; Risk Factors; South Carolina | 2017 |
Empirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Staphylococcal Infections; Survival Analysis; Tertiary Care Centers; Treatment Outcome; Vancomycin; Young Adult | 2017 |
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospectiv
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Superinfection | 2017 |
Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Brazil; Carbapenems; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Stenotrophomonas maltophilia | 2008 |
Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Missouri; Predictive Value of Tests | 2009 |
Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Urinary Tract Infections | 2008 |
Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Shock | 2009 |
Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies | 2009 |
Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Blood; Cerebrospinal Fluid; Child, Hospitalized; Child, Preschool; Hospitals; Humans; Incidence; Infant; Latex Fixation Tests; Meningitis, Pneumococcal; Pneumococcal Infections; Pneumonia, Pneumococcal; Serotyping; Sri Lanka; Streptococcus pneumoniae | 2009 |
[Multiple inflammatory liver pseudotumors and Enterococcus durans bacteremia].
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Biopsy, Needle; Diagnosis, Differential; Enterococcus; Ertapenem; Gram-Positive Bacterial Infections; Granuloma, Plasma Cell; Humans; Liver Abscess; Liver Diseases; Male; Middle Aged | 2009 |
Recurrent bacteremia due to retained embolized glue following variceal obliteration.
Topics: Adult; Bacteremia; beta-Lactams; Embolism; Embolization, Therapeutic; Endoscopy, Gastrointestinal; Ertapenem; Escherichia coli Infections; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Recurrence; Risk Assessment; Severity of Illness Index; Tissue Adhesives; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Catheter-Related Infections; Catheterization, Central Venous; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Female; Glycopeptides; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Young Adult | 2009 |
Previous ciprofloxacin exposure is associated with resistance to beta-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult | 2009 |
Risk factors and outcome in extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2009 |
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2009 |
A case of unforeseen intractable severe bacteremia due to Acinetobacter baumannii--an efficacy of sulbactam--.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Blood; Female; Humans; Middle Aged; Sulbactam; Treatment Outcome | 2009 |
Molecular characterization of extended-spectrum cephalosporinase-producing Salmonella enterica serovar Choleraesuis isolates from patients in Thailand and Denmark.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactams; Blood; Cephalosporinase; Child; Child, Preschool; Cluster Analysis; Denmark; DNA Fingerprinting; DNA, Bacterial; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Polymorphism, Restriction Fragment Length; Salmonella arizonae; Salmonella Infections; Thailand; Young Adult | 2010 |
Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Taiwan | 2009 |
Carriage of qnrA1 and qnrB2, blaCTX-M15, and complex class 1 integron in a clinical multiresistant Citrobacter freundii isolate.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Catheter-Related Infections; Citrobacter freundii; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Integrons; Male; Molecular Sequence Data; Plasmids; Portugal; Quinolones; Sequence Analysis, DNA | 2010 |
New Delhi metallo-beta-lactamase: a cautionary tale.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; India; Microbial Sensitivity Tests | 2010 |
Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms.
Topics: Aged; Aminoglycosides; Bacteremia; beta-Lactams; Enterobacteriaceae; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pseudomonas aeruginosa | 2010 |
Recurrent vascular catheter-related bacteremia caused by Delftia acidovorans with different antimicrobial susceptibility profiles.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Catheter-Related Infections; Catheters, Indwelling; Child; Delftia acidovorans; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Japan; Microbial Sensitivity Tests; Neuroblastoma; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; RNA, Ribosomal, 16S | 2011 |
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
Topics: Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; beta-Lactams; Cross Infection; Drug Combinations; Drug Evaluation; Female; Humans; Logistic Models; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2011 |
Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Australia; Bacteremia; Bacterial Infections; Bacteriological Techniques; beta-Lactams; Cancer Care Facilities; Disease Management; Drug Resistance, Multiple, Bacterial; Fever; Humans; Immunocompromised Host; Neoplasms; Neutropenia; Risk Assessment; Severity of Illness Index | 2011 |
Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Taiwan | 2011 |
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome | 2011 |
Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Ertapenem; Female; Genotype; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Porins; Risk Factors; Treatment Outcome | 2011 |
Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.
Topics: Adult; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Clostridioides difficile; Clostridium Infections; Comorbidity; Humans; Male; Ohio; Treatment Outcome; Vancomycin | 2011 |
De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients.
Topics: Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Critical Care; Decision Trees; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Japan; Male; Middle Aged; Penicillins; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cluster Analysis; Colistin; Drug Resistance, Bacterial; Enzyme Inhibitors; Genotype; Hospitals, Veterans; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Sequence Analysis, DNA; Sulbactam; Taiwan | 2011 |
Method for phenotypic detection of extended-spectrum beta-lactamases in enterobacter species in the routine clinical setting.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Clinical Laboratory Techniques; Enterobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Predictive Value of Tests | 2011 |
Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cell Membrane; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Membrane Potentials; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2011 |
High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Glycopeptides; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2011 |
Central venous catheter-associated Nocardia bacteremia in cancer patients.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Biofilms; Catheterization, Central Venous; Catheters, Indwelling; Drug Therapy, Combination; Female; Humans; Male; Microscopy, Electron, Scanning; Neoplasms; Nocardia Infections; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cross-Sectional Studies; Female; Fluoroquinolones; Genes, Regulator; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; New York; Risk Factors; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2011 |
Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cohort Studies; Drug Therapy, Combination; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Retrospective Studies; Treatment Outcome | 2011 |
Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Propensity Score; Thienamycins | 2012 |
Dissemination of extended-spectrum β-lactamase-producing Escherichia coli at home: a potential occupational hazard for healthcare workers?
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Female; Humans; Ireland; Male; Microbial Sensitivity Tests; Middle Aged; Physicians; Spouses | 2012 |
Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; beta-Lactams; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Models, Biological; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2012 |
Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Ertapenem; Female; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome | 2012 |
Distribution and phenotypic and genotypic detection of a metallo-β-lactamase, CphA, among bacteraemic Aeromonas isolates.
Topics: Aeromonas; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2012 |
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vancomycin; Vancomycin Resistance | 2012 |
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult | 2012 |
First report of spontaneous intrapartum Atopobium vaginae bacteremia.
Topics: Actinobacteria; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Clindamycin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Molecular Sequence Data; Pregnancy; Pregnancy Complications, Infectious; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2012 |
Antimicrobial therapy for bloodstream infection due to methicillin-susceptible Staphylococcus aureus in an era of increasing methicillin resistance: opportunities for antimicrobial stewardship.
Topics: Adult; Anti-Infective Agents; Bacteremia; beta-Lactams; Female; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2012 |
Molecular diversity associated with the dissemination of CTX-M-15 beta-lactamase gene in blood culture isolates of Escherichia coli from Edinburgh.
Topics: Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; Scotland | 2013 |
Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Comorbidity; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Phenotype; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin Resistance | 2013 |
The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Community-Acquired Infections; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Incidence; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Multilocus Sequence Typing; Polymerase Chain Reaction; Prevalence; Retrospective Studies | 2013 |
Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Thienamycins; Treatment Outcome | 2013 |
Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Creatine Kinase; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Male; Registries; Renal Insufficiency; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2013 |
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones | 2002 |
Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Macrolides; Male; Middle Aged; Mortality; Multivariate Analysis; Pneumonia, Pneumococcal; Retrospective Studies; Treatment Outcome | 2003 |
Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; beta-Lactams; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pneumococcal Infections; Retrospective Studies; Treatment Failure | 2003 |
Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae | 2003 |
Prevalence of extended-spectrum beta-lactamase-producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Enterobacter; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; India; Infant, Newborn; Klebsiella; Microbial Sensitivity Tests; Prevalence | 2003 |
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Drug Resistance, Microbial; France; Humans; Infant; Lactams; Microbial Sensitivity Tests; Pneumococcal Infections; Sampling Studies; Sensitivity and Specificity; Streptococcus pneumoniae | 2003 |
Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2004 |
In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2005 |
Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.
Topics: Acetyltransferases; Aged; Amino Acid Sequence; Bacteremia; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Greece; Humans; Imipenem; Integrons; Lactams; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction | 2005 |
Extended-spectrum beta-lactamase-conferring transferable resistance to different antimicrobial agents in Enterobacteriaceae isolated from bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2005 |
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; Bacteria; beta-Lactams; Colistin; Colony Count, Microbial; Drug Therapy, Combination; Escherichia coli; Humans; Microbial Sensitivity Tests; Neutropenia; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 2005 |
Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Administration Schedule; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin | 2006 |
A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; China; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; Sequence Homology; Wound Infection | 2006 |
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical | 2006 |
Antibiotics selection for bacteremic pneumonia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Macrolides; Ofloxacin; Pneumonia, Bacterial; Treatment Outcome | 2007 |
Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome | 2007 |
Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacteria, Aerobic; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Taiwan | 2007 |
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Multivariate Analysis; Pilot Projects; Risk Factors; Spain | 2008 |
Predictors of mortality among patients with community-onset infection due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand .
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Case-Control Studies; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Thailand | 2008 |
Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blood; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Serratia Infections; Serratia marcescens; Taiwan | 2008 |
In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus | 1995 |
In vitro interactions between different beta-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Drug Therapy, Combination; Enterococcus; Fosfomycin; Microbial Sensitivity Tests | 1995 |
Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.
Topics: Amino Acid Sequence; Anemia, Aplastic; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA Fingerprinting; DNA Probes; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Female; Humans; Infant; Isoelectric Focusing; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction | 1997 |
Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria, Aerobic; Bacterial Infections; beta-Lactams; Blood; Culture Media; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Naphthyridines | 1998 |
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Conjugation, Genetic; DNA Fingerprinting; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Oncology Service, Hospital; Pediatrics; Plasmids; Polymerase Chain Reaction | 1999 |
Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital.
Topics: Bacteremia; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Mexico; Microbial Sensitivity Tests | 2001 |
Beta-lactam modification of the bacteraemic profile and its relationship with mortality in a pneumococcal mouse sepsis model.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumococcal Infections; Sepsis | 2002 |